Placeholder Banner

Stopping ALS: An interview with Dr. Perrin from ALS TDI

August 15, 2011
What is ALS? How widespread is the disease? Are there any treatments for ALS?

Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease and outside the US as Motor Neuron Disease (MND) or Charcot's Disease, is a progressive neurodegenerative disease that attacks motor neurons in the brain (upper motor neurons) and spinal cord (lower motor neurons) and affects muscle function.

Dr. Steven Perrin is the CEO, CSO and Vice Chairman of the ALS Therapy Development Institute. ALS TDI combines the passion and dedication of a nonprofit organization with the entrepreneurial and scientific spirit of a biotechnology company to find effective treatments for the disease. Recently, he took a few minutes to speak with BIOtech-NOW about his organization's innovative approach.